España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SciSparc
SPRC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.226700
-0.0042
-1.82%
At close: -
$0.228000
0.0013
0.57%
After Hours: 7:52 PM EDT
Get Report
Comment
SciSparc (SPRC) Forecast
News
Earnings
SciSparc (SPRC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for SciSparc (NASDAQ:SPRC) Stock
SciSparc Stock (NASDAQ: SPRC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, October 01, 2024
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
Rolando García
Monday, September 30, 2024
SciSparc Receives FDA Approval To Launch Pivo...
Benzinga Newsdesk
Thursday, September 26, 2024
SciSparc Signs Non-Binding Letter of Intent t...
Benzinga Newsdesk
Monday, September 23, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Receives FDA Approval To Initiate Ph...
Benzinga Newsdesk
Wednesday, September 18, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Submits IND Application To FDA For P...
Benzinga Newsdesk
Tuesday, September 17, 2024
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Juan Spínelli
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, September 11, 2024
SciSparc Announced That It Had Entered Into A...
Benzinga Newsdesk
Thursday, August 29, 2024
Clearmind Medicine Announces Publication Of P...
Benzinga Newsdesk
SciSparc shares are trading lower after the c...
Benzinga Newsdesk
Reported August 28: SciSparc Files For Sale O...
Benzinga Newsdesk
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, August 28, 2024
SciSparc Grants Global Rights For Pain Therap...
Benzinga Newsdesk
Monday, August 26, 2024
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 23, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Submits IND Application To The FDA F...
Benzinga Newsdesk
Tuesday, August 20, 2024
Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients
Jelena Martinovic
Monday, August 19, 2024
SciSparc Enrolls First Five Patients In Clini...
Benzinga Newsdesk
Israel-Based Biotech Penny Stock SciSparc Outlicenses Its Cannabinoid Pain Therapy
Vandana Singh
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 16, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Finalizes Exclusive Global Out-Licen...
Benzinga Newsdesk
Thursday, August 15, 2024
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
Avi Kapoor
Dow Surges Over 500 Points; US Retail Sales Rise In July
Avi Kapoor
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, August 14, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Reports Court's Approval Of AutoMax'...
Benzinga Newsdesk
Tuesday, August 06, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc's And Clearmind Medicine Collaborati...
Benzinga Newsdesk
Monday, July 22, 2024
SciSparc Announces MitoCareX Confirms Potenti...
Benzinga Newsdesk
Wednesday, July 17, 2024
SciSparc Announced That It Has Signed A Non-b...
Benzinga Newsdesk
Tuesday, July 16, 2024
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
SciSparc Receives Notification From Nasdaq Re...
Benzinga Newsdesk
Thursday, July 11, 2024
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, July 08, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Signs Non-Binding Letter Of Intent T...
Benzinga Newsdesk
Friday, May 31, 2024
SciSparc Says European Patent Office Granted ...
Benzinga Newsdesk
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, April 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
Akanksha Bakshi
SciSparc shares are trading higher. The compa...
Benzinga Newsdesk
SciSparc To Acquire AutoMax, Terms Not Disclo...
Benzinga Newsdesk
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, April 09, 2024
SciSparc Granted Canadian Patent #2984088 Tit...
Benzinga Newsdesk
Wednesday, March 27, 2024
SciSparc- Clearmind Collaboration Evolves Wit...
Benzinga Newsdesk
Thursday, March 21, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
Show More